
8. juni 2010:Pressemeddelelse nr. 5, 2010: Zealand Pharma Announces An Extension of The Lixisenatide...
The 31st European Peptide Symposium, Copenhagen, Denmark, 5-9 September 2010 (Science) 46th An...
Vision
Mission
Zealand’s overall focus is to create maximum value for its investors by bringing innovative peptide drugs with significant therapeutic and commercial potential rapidly and efficiently to the market to meet patients’ unmet clinical needs.
Fill in the form below to tip a friend about this page.
When this page is updated you will be updated by e-mail.
Home Legal Disclaimer Updated: 27.7.2010